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| INTRODUCTION
Osteoporosis is a prevailing skeletal disease globally. The deteriorated bone microarchitecture increases the probability of fragility fractures that would affect the quality of life of the patients. Previous studies reported decreased osteocyte and lacunar-canalicular density with age. 1 Fewer canaliculi and lower connectivity were also observed in aged bones of rodents and older women. 2, 3 Understanding the healing mechanisms of osteoporotic fracture and how they respond to different biophysical stimulation such as mechanical stimulation might provide possible therapeutic interventions clinically that could accelerate and improve osteoporotic fracture healing.
Bone repair is a complex physiological process that requires dynamic coordination of cells. Researches in osteoblasts and osteoclasts have been reported extensively. Osteocytes, which are embedded in the calcified bone matrix in a three-dimensional (3D) cellular network, are relatively understudied. Current studies have provided a better understanding of the interconnection of neighboring osteocytes through extensive dendritic processes in the osteocyte lacuna-canalicular network (LCN). The unique structure of the LCN can facilitate efficacious physical, chemical, and biological molecular exchanges through an extensive surface area for bone homeostasis. 4, 5 Osteocyte is one of the major cell types in bone, responsible for mechanosensing through their complex dendritic network, 6 cell body and bending of cilia. 7, 8 However, aging-related changes in the structure and function of osteocyte LCN might alter the ability of osteocytes to sense mechanical loading, orchestrate bone remodelling 9 and detect microdamage by fluid flow 10 resulting in delayed insufficient bone repair and fragile bone. Emerging evidence showed that osteocytes could release secretory factors at the fracture site 11, 12 and facilitate bone regeneration by robust cellular recruitment during fracture healing. 13 Osteocytes expressed proteins known to play profound roles during the healing process. E11 is called gp38 in murine and gp36 in human. It is a transmembrane glycoprotein, an indicator of osteoblast-osteocyte transition (osteocytogenesis) and distributes in multiple tissues with cells requiring dendrites morphology and were constantly expressed throughout the stages of repair for osteogenesis. 14 Dentin matrix protein 1(DMP1) is predominantly expressed in osteocyte, which acts as a major regulator of the osteocyte LCN, mineralization, 15, 16 and response to mechanical loading. 17 Fibroblast growth factor 23 (FGF23) acts as a putative marker for bone healing and regeneration. 18 Although a considerable number of studies have started to discover the functional role of osteocytes, the critical underlying mechanism regulated by osteocytes during fracture healing is still poorly understood.
Low-magnitude high-frequency vibration (LMHFV) is a noninvasive biophysical intervention shown to accelerate osteoporotic diaphyseal fracture healing. Previous reports have demonstrated that callus formation, mineralization 19 and remodelling 20 were all augmented by LMHFV in both normal and osteoporotic fracture healing. However, most osteoporotic fractures occur at the metaphyseal regions of bones, 21 including distal radius, proximal humerus, or proximal femur. 22 To date, limited number of studies use osteoporotic metaphyseal fractures models. 23 Therefore, a new reproducible animal model is essential to acquire a better understanding of metaphyseal healing in osteoporotic fracture.
Based on the above evidence, it was hypothesised that mechanical stimulation in the form of LMHFV could enhance the structural morphology of the LCN, mineralization and alter the expression of osteocyte-specific markers during metaphyseal fracture healing. The objective of the study was to analyse the morphological changes, mineralization status and osteocyte-specific protein markers expression profile of osteocyte LCN in response to LMHFV in an ovariectomized and sham metaphyseal fracture rat model.
| MATERIALS AND METHODS

| Study design
This is an animal study to investigate the ultrastructural and functional changes in the osteocyte LCN in response to LMHFV in sham and ovariectomy-induced osteoporotic metaphyseal fracture healing. LCN morphology was assessed and quantified by acid-etching Scanning Electron Microscopy (SEM) and fluorescein isothiocyanate (FITC)-Imaris. Protein expression was evaluated by immunohistochemistry (IHC) staining. Bone mineralization was examined with SEM-Energy-dispersive X-ray Spectrometry reveal the enhancement effect of LMHFV on the osteocytes' morphology and functions in osteoporotic fracture healing.
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| Femoral metaphyseal fracture rat model
One hundred and eighty three female Sprague Dawley rats (three excluded in the study) were obtained from the Laboratory Animal Services Centre of the Chinese University of Hong Kong. Half of the rats underwent bilateral ovariectomy at 6 months under general anesthesia and were subsequently aged for three months to develop ovariectomized (OVX) according to our established protocol. 19 To assess the changes in bone mineral density (BMD), dual energy X-ray absorptiometry (DXA; UltraFocus, Faxitron, Houston, TX, USA) was performed for each rat under general anesthesia, pre-ovariectomy at six months and pre-fracture induction at nine months. BMD at the lumbar spine, proximal femur, and distal femur were measured. A metaphyseal fracture was created at the left distal femur of the rats at the age of nine months. A 2.5 cm lateral incision was created along the left thigh to expose the distal femoral condyle for the osteotomy. A 6-hole 1.0 mm T-shaped mini-plate (T-plates, Bioortho, China) was used to fix the lateral femur with five screws inserted perpendicular to the femur. A small ultrasonic saw with 0.35 mm in width (OT7S-3, Piezosurgery Touch, Metron, Italy) was used to create an osteotomy at the metaphysis. The osteotomy cut was made at the metaphysis immediately proximal to the growth plate. Buprenorphine (0.03 mg/kg sc. Temgesic, Schering-Plough, NJ) was given postoperatively for analgesics. All rats were allowed free cage movement and ad libitum access to standard rat diet and tap water. All treatments of animal were in accordance with the ARRIVE guidelines.
| Grouping and interventions
The rats were randomly divided into four groups (n = 6 rats/ group/time point): sham control (SHAM-CT), sham vibration (SHAM-VT), ovariectomized control (OVX-CT), and ovariectomized vibration group (OVX-VT). The rats in SHAM-VT and OVX-VT stood in a bottomless, compartmented cage on the vibration platform (V-Health Ltd, Hong Kong) for 20 min/day, 5 days/week starting from 2 days after fracture creation. 24 The vibration platform provided vertical LMHFV signals at 35 Hz with a peak-to-peak acceleration of 0.3 g (g = gravitational acceleration). The rats in SHAM-CT and OVX-CT stood on an unpowered vibration platform as sham treatment with the same regime. Each group was harvested at three time points: 7, 14, or 42 days post-fracture.
Seventy-two rats underwent µCT measurements on days 7, 14, and 42 post-osteotomy (n = 6 rats/group), followed by SEM analysis (n = 3 rats/group/time point) and FITC-Imaris analysis (n = 3 rats/group/time point). For immunohistochemical analysis, 48 rats (n = 4 rats/group/time point) were euthanized. An additional 48 rats (n = 6 rats/group), were euthanized at 14 and 42 days post-osteotomy to undergo biomechanical testing on the osteotomized and intact limbs. Twelve rats were further euthanized on days 42 for dynamic histomorphometry measurements (n = 3 rats/group). All rats regained full weight-bearing walking post-fracture before commencing treatment. No panic behaviors nor weight loss were observed during the LMHFV treatment. In all groups, three rats were excluded due to anaesthesia-related death; an additional three rats were included before group allocation. The study was approved by The Chinese University of Hong Kong Animal Experimental Ethics Committee (Ref. No. 17-004-GRF-5-C).
| Bone histomorphometry
Dynamic histomorphometric evaluation was performed to access the degree of mineralization in the endosteal bone region. Xylenol orange (90 mg/kg sc. Sigma) and calcein green (5 mg/kg sc. Sigma, Deisenhofen, Germany) were injected 1 and 2 weeks into the rats (n = 3) prior to euthanasia, respectively. After µCT scanning, the fractured femora were dehydrated serially for undecalcified histomorphometry according to our established protocol. 25 The embedded samples were sectioned sagittally by saw microtome (Leica SP1600, Leica, Nussloch, Germany), ground, and polished to 100 µm before analysis. The fluorescence labelling at day 42 postfracture were observed under an ultraviolet fluorescent microscope (Leica Q500MC, Leica, Germany) and analyzed using the OsteoMeasure high-resolution digital video system (OsteoMetrics Inc., Decatur, GA, USA). 20
| Acid-etched scanning electron microscopy (SEM)
Qualitative analysis of the ultrastructure of LCN was performed according to Feng's protocol. 26 Bone slices at a thickness of 150 μm were immersed in 37% phosphoric acid, then in 5% sodium hypochlorite. The etched bone sections were polished, sputter-coated with gold and palladium and examined with SEM (Hitachi SU8100, Japan) under 5 keV accelerating voltage, 10 μA probe current, 15 mm working distance and image resolution at 1560 × 1920. SEM images were taken at different magnifications from 200× to 4000× for assessing osteocytes' distribution, morphology, orientation, and dendritic connectivity. The ROI was set 0.5 mm proximal and distal to the fracture site in the endosteal cortical bone region.
| Energy-dispersive X-ray spectrometry analysis
The SEM with an energy-dispersive X-ray microprobe (Sedona SD detector, IXRF system) was used to measure the mineral content and composition of the bone matrix. 27 The accelerating voltage was set at 15 kV, and the working distance at 10 mm. Three representative bone specimens were selected randomly from each group. For each specimen, the corresponding relative elemental mapping, composition and mineral components 0.8 mm proximal and distal to the fracture line were examined. The relative concentrations of calcium (Ca%), carbon (C%), and phosphorus (P%) were quantified with the correction of atomic number and absorption for each analysis. 28 The ratios of the calcium-phosphorus (Ca/P), carbon-calcium (C/Ca), and carbon-phosphorus (C/P) were determined. 29 
| Confocal laser scanning microscopy
Confocal microscopy was performed to capture the images for the ultrastructural analysis three-dimensionally. After dehydration, the bone samples (n = 3) were subjected to FITC stain (Sigma-Aldrich) overnight, followed with additional dehydration and Methylmethacrylate (MMA) embedding as above. 30 The MMA sections were ground to a thickness of 130 μm for confocal imaging (SP8 Leica, Germany). The samples were subjected to 488-nm wavelength excitation using an argon laser and emission at 520 nm. All images were captured at light ranging from 500 to 540-μm wavelengths. Multiple stacked images were taken at 200 Hz and 1024 × 1024 dimensions using 63× glycerol objective lenses at 1.5× magnification. 30 For all samples, a thickness of 40 μm was obtained with a pixel size of 0.1542 μm × 0.1542 μm × 0.29 μm from the fractured femoral cortical bone area.
| Three-dimensional (3D) reconstruction and quantification of osteocyte LCN
Quantitative morphologic changes of LCN were evaluated by quantitative FITC-Imaris technique according to previous protocols. 30, 31 The stacked pictures, which included at least three osteocytes in one sample region, were processed for deconvolution and subsequently analyzed by Imaris (Bitplane, Zurich, Switzerland).
The 3D structure of the osteocyte network was constructed from a z-series of images using Imaris software (Bitplane, Zürich, Switzerland) by mapping fluorescence-positive sites. The diameters of the osteocyte cell bodies and parameters of dendrites were measured by rotating the 3D-reconstructed images. The surface area and volume of a single osteocyte were measured by surface rendering using the surface function of Imaris. The osteocyte network was quantified by measuring the total dendritic length and branching points. Average total length of the dendrites, average surface area, average volume, average number of branching points, and average number of segments per osteocyte were calculated by dividing by the number of osteocytes analyzed.
| Immunohistochemistry
Protein expression was evaluated by immunohistochemical staining at close vicinity in the cortical region of fracture sites. The harvested femora (n = 4 rats/group) were fixed in 9% neutral buffered formalin solution. These specimens were decalcified in buffered formic acid, paraffin embedded, and sectioned at 5 μm thickness. To detect the expression of DMP1, E11, sclerostin (Sost), and FGF23, immunohistochemistry was conducted on sections by a detection kit (ab64264, abcam). 32 Anti-DMP1(LS-B1122650, LifeSpan, US), anti-E11 (bs-1048R, Bioss, Shanghai, China), anti-Sost (ab63097, abcam), and anti-FGF23 (LS-C411984, LifeSpan, US) were used, followed by secondary antibodies. The sections were counterstained with hematoxylin and analyzed using image analysis software (ImageJ, USA). The number of osteocytes with positive signals were counted at ROI (5 mm proximal and distal to the fracture line), where a total of four slides at a high power field (40×) of the best quality were used for taking the average of one sample. 33 
| Serial radiographic analysis
To assess the healing processes, lateral X-rays (UltraFocus DXA, Faxitron, IL) were taken weekly at 60 kVp and 3.0 s to monitor the fracture healing status. The metaphyseal osteotomy sites were manually selected and the radiopacity was quantified with image analysis software (ImageJ, USA). 34 
| MicroCT imaging
To assess the bone microarchitecture and degree of bone healing, the fractured femora were harvested and scanned | 5
with µCT postmortem (µCT40, Scanco Medical, Brttisellen, Switzerland) at day 7, 14, and 42 post-fracture according to our established protocol. 25 All plates and screws were removed before any scans to avoid metal artefacts. The scan range was set to 1.8 mm above and below the osteotomy site to avoid the diaphyseal region. Selection of region of interest (ROI) from 2D images and 3D reconstruction of mineralized tissue were performed. The low (150-350) and high density (>350) analyses were performed in order to distinguish woven bone from old cortical bone or laminar bone, according to our protocol. 19 Morphometric parameters were evaluated, including bone volume (BV, mm 3 ), tissue volume (TV, mm 3 ), bone volume fraction (BV/TV), and bone mineral density (BMD, mg HA/cm 3 ). Microarchitectural parameters were evaluated in terms of trabecular number (Tb.N), trabecular thickness (Tb.Th), and trabecular separation (Tb.Sp). All assessments and nomenclature follow the guidelines. 35 
| Mechanical testing
Biomechanical testing was performed to assess the biomechanical properties during healing. Forty-eight rats (n = 6 rats/group) were euthanized at 14 and 42 days postfracture for biomechanical testing on the fractured and contralateral intact limbs. 36 Each femur was embedded in a performance polymer (Ureol 2020, Ciba, Hong Kong) at the proximal end and fixed to the material testing machine (H25KS Hounsfield Test Equipment Ltd. Redhill, Surrey, UK) with 25° above the horizontal, where the angle mimics the in situ physiological loading conditions. Compressive force was applied by a metal blade at the epiphysis directly above the second screw hole at a constant downward velocity of 25 mm/min. Load-displacement curves were generated after testing to failure. Ultimate load (N), stiffness (N/mm), and energy to failure (N mm) were recorded and analyzed using built-in software (QMAT Professional Material testing software). The results were normalized with the contralateral intact bones.
| Statistical analysis
All measurements were expressed as mean ± standard deviation (SD). All data were expressed in mean ± standard deviation. A multivariate analysis of variance (ANOVA) test was used to analyse the main effects amongst SHAM/OVX, vibration treatment and time points. Post-hoc multiple comparisons corrected by Bonferroni adjustment was performed when significant main effects were detected. When significant interaction was detected, further comparisons between VT and CT groups were conducted. All statistical analyses were performed with SPSS 20.0 (IBM, NY, USA). Statistical significance was set at P < .05.
| RESULTS
| LMHFV revitalized osteocyte LCN in both normal and osteoporotic fracture healing
Low-magnitude high-frequency vibration was found to have significant effect on the ultrastructure of osteocyte LCN in the metaphyseal osteoporotic fracture model. From the SEM images, lengthening of dendrites in the osteocytes was seen from the early to late stage post-fracture, with remarkable increase in OVX-VT group, while a sparse distribution of canaliculi was observed in OVX-CT group (Figures 1 and 2 ). For dendritic branch points, significant differences were found in these two main effects, that is, time point (P = .005) and treatment (P = .024). Therefore post-hoc test was carried out to compare the differences between treatment across time points. No significant interaction was detected in canalicular length. After quantification, there was an increase of 20% of dendritic branch points in OVX-VT group when compared to OVX-CT group at day 7. At day 14, there was a 65% significant increase in the number of dendritic branch points (P = .03) and 93% increase in canalicular length (P = .019) aligned in irregular clusters in the OVX-VT group when compared to the OVX-CT group. At day 42, the osteocytes in OVX-VT group had 51% more densely branched canaliculi and 68% increase in length, as compared with OVX-CT group. With LMHFV treatment, the osteocyte LCN exhibited a more vibrant morphology with an exuberant outgrowth of canaliculi in the OVX-VT group as compared with the OVX-CT group.
Besides, the enhancement effect was also observed in the SHAM-VT group, with a dramatic outburst of dendrites after LMHFV (Figures 1 and 2) . The results showed a similar trend of increase as in the OVX-VT group. Despite statistical difference not found in the SHAM-VT group, the number of branch points was elevated by 15% at day 7, 43% at day 14, and 18% at day 42 when compared to the SHAM-CT group. Consistently, the canaliculi length was increased dramatically by 157% at day 14 and 17% at day 42 ( Figure 2B ,C).
A general trend was observed after the intervention of LMHFV in the total surface area and volume in all the groups with no significant interactions detected. The total surface area of lacuna had a general increase in OVX-VT group than in OVX-CT group, with an increase of 8% and 47% at day 7 and 42, respectively ( Figure 2D ,E). Interestingly, at the intermediate phase of day 14, where the osteocytes experienced a dramatic increase of dendritic processes, the total surface area was slightly lowered in both OVX-VT and SHAM-VT groups. The SHAM-VT group showed a general increasing trend of total surface area by 50% at day 7 and 35% at day 42, but decreased by 53% at day 14. Meanwhile, the total cell volume per osteocyte increased to a greater extent in the OVX group. The total volume increased steadily by 45% at day 7, 48% at day 14, and 56% at day 42 in OVX-VT group than in OVX-CT group. However, the total cell volume per osteocyte decreased by 22% and 13% at both day 7 and 14 in the SHAM-VT group, but a slight increase by 9% at day 42 ( Figure 2E ). Thus, the LMHFV treatment could significantly improve the LCN and showed trends of increase in surface area with a substantial increase in the canaliculi number and length as healing progressed, and the effect on these osteocyte-related morphologies was greater in the OVX group compared to the SHAM group.
| LMHFV enhanced the expression of osteocytic proteins during fracture healing
To investigate the effect of LMHFV at molecular level, osteocyte-specific markers were analyzed at close vicinity of fracture at post-fracture day 7, 14, and 42 (Figure 3 ). Immunohistochemistry demonstrated DMP1 expression was upregulated at the early and intermediate phase in fracture healing and declined at day 42 in the OVX groups. Significant interaction was detected in OVX/SHAM × time point (P = .035) in this observable increase of DMP1 expression after vibration. Therefore post-hoc test was carried out to compare the differences between control and vibration across time points in both OVX and SHAM groups. In OVX-VT group, a significant increase of DMP1 expression was found at day 7 by 97% (P = .019) and at day 14 by 66% (P = .036), while no statistical difference was found at day 42, and the expression declined significantly by 39% from day 14 to day 42 (P = .039). In the SHAM groups, DMP1 expression was generally increased at day 7 by 21% and day 42 by 45% after vibration. The increased trend of OVX-VT group was comparable or even greater than SHAM-VT group. Regarding Sost expression, there was a significant difference between OVX and SHAM group (P = .035) with higher expression in the SHAM group. Significant interaction was found in treatment × time point (P = .001) and thus post-hoc test was conducted to compare the differences between control and vibration across time points. Although no statistical difference was found at day 7 and day 14 between the OVX-CT group and OVX-VT group, the number of Sostpositive osteocytes in OVX-VT group were greatly reduced in comparison with OVX-CT group. In the OVX-VT group, the level of expression increased significantly from day 14 to day 42 (P = .05), and increased dramatically with a significant enhancement of 263% as compared with the OVX-CT group (P = .04) at day 42. In the SHAM-VT group, Sost was generally downregulated by 70% at day 14 but upregulated by 58% at day 42 as compared to the SHAM-CT group. For both OVX-VT and SHAM-VT groups, the expression had started to decline after the LMHFV treatment at day 7 and 14, but increased with peak expression at day 42, as compared with their corresponding controls. Furthermore, significant OVX/SHAM*time point interaction was detected (P = .01), and post-hoc analysis was carried out. Peak expressions were seen at day 7 for both SHAM-VT and OVX-VT groups in comparison with their corresponding control groups. The increasing trend was continuously observed in SHAM-VT group till day 42, whereas OVX-VT group exhibited a subsiding E11 expression as compared with OVX-CT.
E11 protein expression was elevated significantly by 73% in OVX-VT group than in OVX-CT group at day 7 (P = .01). In SHAM-VT group, the E11 expression was greatly enhanced at all time points with significant increase at day 14 (P = .037) by 238% and at day 42 increased by 287% (P = .048), as compared with SHAM-CT group.
In the OVX-VT group, FGF23 was upregulated at all time points as compared with the OVX-CT group, with an 80% enhancement at day 42 (P = .001). For SHAM-VT group, FGF23 increased significantly at day 7 by 313% (P = .001) and day 42 by 143% (P = .048), when compared to the SHAM-CT group. FGF23 protein expression was enhanced at all time points in both vibration groups.
| LMHFV accelerated bone healing in the osteoporotic metaphyseal model
Generally, better healing outcomes were seen after the intervention of LMHFV in both OVX-VT and SHAM-VT groups as shown by the results of radiography, histology, microCT, and mechanical testing. Serial radiographic images exhibited an increasing radiopacity from early to late phase during healing (Figure 4) . A significant increase of radiopacity was found in OVX-VT group at all time points as compared with OVX-CT (P = .000; P = .002; P = .03 for day 7, 14, 42, respectively). Significantly increased radiopacity was also observed in SHAM-VT group at day 14 (P = .01) and day 42 (P = .005) when comparing to the SHAM-CT group. As indicated by the representative histological photos, the healing progressed with endosteal bridging of fibrous and osseous tissue at day 14. At day 42, advanced healing was signified by mature woven bone along the fracture gap. No significant periosteal callus and cartilaginous tissue were observed during the healing process suggested that the model was primarily healed by intramembranous ossification ( Figure 6 ).
MicroCT analysis indicated that significant OVX/ SHAM × time point interaction (P = .000) and treatment × time point interaction (P = .004) were detected. The analysis showed that all OVX and SHAM groups demonstrated a general increasing trend of total bone volume (BV) from day 7 to day 42 ( Figure 5C ). BV started to increase at day 7 in the OVX-VT group, while increased rapidly at day 14 in SHAM-VT group. The OVX-VT rats demonstrated a significant increase of BV than OVX-CT group at day 14 (P = .038), while SHAM-VT group showed a significant increase than SHAM-CT group at day 42 (P = .033).
For total volume (TV), a general increase was seen from day 7 to day 14 in all four groups and declined from day 14 to day 42 ( Figure 5B ). The effect of vibration was greater in the OVX group at day 14 till 42.
Bone volume fraction (BV/TV) demonstrated significant interactions was found in OVX/SHAM × treatment (P = .00) and treatment × time point (P = .00). In general, BV/TV increased from day 7 to day 42 in all groups ( Figure 5D ) and both SHAM-CT and SHAM-VT group had a higher BV/TV than the OVX groups. Both OVX-VT and SHAM-VT groups increased rapidly at day 14 and the effect of vibration treatment was more robust since day 7 in OVX-VT, while at day 14 in SHAM-VT group. In OVX-VT group, a significant increase in BV/TV was seen in OVX-VT than OVX-CT at day 14 (P = .008). Both vibration groups of OVX-VT (P = .02) and SHAM-VT (P = .01) showed a significantly higher BV/ TV at day 42, as compared with their corresponding control groups.
Structurally, significant OVX/SHAM × time point interaction (P = .00) and treatment × time point interaction were found ( Figure 5F ). Tb.Th increased more significantly after vibration and the degree of enhancement was greater in SHAM-VT group than in OVX-VT group. In the OVX-VT group, Tb.Th increased steadily from day 7 and raised rapidly from day 14 to 42, while the OVX-CT group decreased from day 14 to 42. For the SHAM groups, no significant difference was seen at day 7, however, significant increase in SHAM-VT group was seen at day 42 when compared to day 7 and 14. At day 42, significantly higher Tb.Th were seen in both OVX-VT (P = .001) and SHAM-VT (P = .05) groups in comparison with the OVX-CT and SHAM-CT groups, respectively.
For Tb.Sp, significant interactions were found in the OVX/SHAM*time point interaction (P = .00) and treatment × time point interaction (P = .003). The SHAM-CT group had decreased Tb.Sp since day 7, while the OVX-CT group decreased from day 14. Vibration lowered the Tb.Sp at all time points in the OVX-VT group and more pronounced at day 42 in SHAM-VT group ( Figure 5G) . Conversely, Tb.N was increased generally in the OVX-VT group from day 7 to 42. In SHAM-VT group, Tb.N was found significantly greater (P = .04) as compared with the SHAM-CT group at day 42 ( Figure 5E ). Significant OVX/SHAM × treatment interaction (P = .012), OVX/SHAM × time point interaction (P = .00) and treatment × time point interaction (P = .00) were detected. Both SHAM and OVX vibration groups increased rapidly from day 14 to day 42, whereas the trend was opposite between the SHAM-CT and OVX-CT groups. In the SHAM group, both the control and vibration groups decreased from day 7 to day 14, and significant increase was seen at day 42 in the SHAM-VT group.
Biomechanical analysis revealed that the SHAM group had an overall higher ultimate load when compared to the OVX group ( Figure 6B-D) . OVX-VT group exhibited a significantly higher ultimate load by 105% (P = .036) and stiffness by 151% (P = .024) than OVX-CT group at day 14 (P = .009). The stiffness in SHAM group was higher than that in the OVX group (P = .00). Higher energy to failure was also observed in all vibration groups (P = .016). Higher energy to failure was seen at day 42 compared to day 14 (P = .001) and significant interaction of OVX/SHAM × time point (P = .044) was detected. A significant increase by 113% was found at day 42 in OVX-VT (P = .022) and OVX-CT group showed the lowest energy to failure among all groups.
| LMHFV enhanced matrix mineralization at the fracture site
From SEM-EDX analysis, a significant enhancement of Ca/P was illustrated in OVX-VT group at day 42 (P = .05) with no significant interactions. C/P and C/Ca ratios decreased in OVX-VT at all time points, with significant difference (P = .03 and P = .034, respectively) at day 42 when compared to OVX-CT group. In SHAM-VT group, there was a significantly lowered C/P at day 7 (P = .05) and day 42 (P = .019) and C/Ca at day 42 (P = .02), as compared with SHAM-CT group. The results were substantiated with BMD data by microCT ( Figure 7D,H) , where significant treatment × time point interaction (P = .002) was found in BMD of bone volume (BV). The post-hoc test showed that significant increase was found in BMD of bone volume (BV) of OVX-VT group at day 42 (P = .04) and at day 14 (P = .043) in SHAM-VT group, while the other two time points had no difference. In the OVX-VT group, BMD of TV were higher in all groups after vibration treatment. Significant difference was demonstrated in OVX-VT group on both day 14 and day 42 (P = .03 and P = .013) than OVX-CT group, whereas a significant increase at day 42 (P = .05) was also demonstrated in SHAM-VT group as compared with SHAM-CT group. A significant enhancement of Ca/P ratio (P = .05), mineral apposition rate (MAR) (P = .007), mineralizing surface (MS/BS) (P = .04) and bone formation rate (BFR/BS) (P = .018) were detected in OVX-VT group than in OVX-CT group at day 42. Yet, there was no significant change found in SHAM-VT group.
| DISCUSSION
In our study, we examined the changes in morphology of the osteocyte LCN and mineralization status from early to late phase during healing. Overall, the results of this study demonstrated a positive enhancement effect of the LMHFV on the osteocyte LCN, mineralization and healing outcomes to a greater extent in osteoporotic bone with significant interactions found in the main effect of vibration treatments. These newly added evidence further support that osteocyte is a crucial mechanosensor that plays an important coordinating role in the repair of osteoporotic fracture.
Our qualitative and quantitative results demonstrated a significant positive morphological change in osteocyte LCN
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Mineralization was promoted at the fracture site after the intervention of LMHFV. SEM-DEX analysis of the mineralization elements evaluated by (A) Ca/P ratio, (B) C/Ca ratio, and (C) C/P ratio along the cortical bone at close vicinity at the fracture site from early to late stage of healing (n = 3 rats/group). Bone mineral density (BMD) of (D) total volume (BMD-TV) and (E) bone volume (BMD-BV) were evaluated by microCT and presented in mg HA/cm3 (n = 6 rats/group). a higher in Day 14 than Day 7, P < .05; b higher in Day 42 than Day 14, P < .05, c higher in Day 42 than Day 7, P < .05. Main effects and interaction detected from multivariate ANOVA coupled with post-hoc Bonferroni test. Dynamic histomorphometry of the bone in the endosteal region were measured in (F) MS/BS%, (G) MAR (mm/day), and (H) BFR/BS (mm 3 /mm 2 / day) at day 42 post-fracture (n = 3 rats/group). Bars represent mean ± SD, *P ≤ .05, vibration group versus control group by t tests in terms of canaliculi number and length after the treatment of LMHFV. In particular at day 14, the enhancement was demonstrated by the Imaris evaluation, E11 and DMP1 expression during the healing process. E11 is responsible for dendrite elongation in response to mechanical strain, 37 while DMP1 is responsible for maintaining the normal morphology of osteocytes. 26 From our results, E11 and DMP1 were both significantly enhanced in the OVX-VT group from early to intermediate phase accompanied by the enhancement of dendritic networks after LMHFV. The morphology of the LCN may reflect the mechano-responsiveness and sensitivity among the osteocyte networks. 38 The osteocytes dendritic connections are crucial to the extracellular matrix in multiple aspects of osteocytes' physiology, detection of microcracks and thereby activating bone remodelling. 39, 40 Furthermore, enhancements in dendritic elongation by LMHFV may imply the osteocytic modification of their microenvironment 37 that might directly influence the subsequent event of bone formation and remodelling. Consistent with previous findings, both the osteoporotic and non-osteoporotic vibration groups demonstrated a better healing outcome as shown by a significant increase in BV and BV/TV when comparing to their corresponding control groups. In addition, the vibration treatment also improved the bone formation in the osteoporotic bone at the late stage. Interestingly, our results reiterated the observation that dendrites were frequently extended and retracted, 41 and the canaliculi exhibited greater change than the lacuna cell surface area and volume. The enhancement effect could promote their viability, mechanotransduction, 42 cross talk between bone cells, 43 thereby improving the process of healing by a higher solute transport rate that linearly correlates with canalicular number. 44 Although no statistical significance was detected between groups in lacuna surface area and volume, the lacuna volume was increased in the OVX-VT group at all time points and the lacuna surface areas were also increased in both the SHAM-VT and OVX-VT groups at day 42 ( Figure 2D ,E). This observation might imply that the lacunae were being actively remodelled by the inhabiting osteocytes through a different mechanosensing mechanism on the cell body that requires further investigations. 45 Osteocytes play profound roles to regulate proteins with their respective functions throughout the healing cascade, from osteogenesis at the early stage, mineralization at intermediate stage and remodelling at late stage of healing. From the immunohistochemical results, we validated that all osteocyte-related proteins exhibited positive responses toward mechanical stimulation. Both E11 and DMP1 are both highly expressed during the stage of pre-osteocytes and osteocyte, 46, 47 and both of them were upregulated at day 7 post-fracture in the OVX-VT groups, indicating that the accelerated cellular transition and the maturation of new woven bone. Our results echoed a previous finding that E11 was constantly expressed throughout the healing cascade 14 with peak expression at day 7 in both OVX and SHAM groups. The elevated E11 expression was found in the OVX-VT group at day 7 and the SHAM-VT group at day 14. DMP1 expression was upregulated at day 7 and 14 in the OVX-VT group. DMP1 mRNA was reported to highly express in pre-osteocytes and osteocytes during fracture healing for bony callus formation at day 14, 48 and their peak expressions were observed along with significant increase in BV and BV/TV in the OVX-VT group. The results indicated that both E11 and DMP1 were upregulated in response to mechanical stimuli and led to the enhanced osteocytic activities during early to intermediate phase of healing. From our results, we observed an inhibitory effect of vibration on Sost at the early stage along with the rapid osteogenic activity. Past studies on Sost −/− mice in fracture healing have observed less cartilage content as well as significantly higher osteoblast and active β-catenin signalling at 14 days post-fracture than that of the wild type. 49 Thus, inhibition of Sost by LMHFV treatment at early to the intermediate stage may lead to earlier progression of the metaphyseal fracture healing with less endochondral ossification but more intramembranous ossification.
Besides the osteogenic properties, DMP1 null mice exhibited impaired mineralization 16 demonstrating its direct role in bone mineralization during the initial stages of nucleation. 50 Furthermore, DMP1 regulates FGF23 production through a common pathway involving FGF receptor (FGFR) signalling. 51 FGF23 maintains local mineralization in bone extracellular matrix by regulating systemic mineral metabolism via the regulation of phosphate and vitamin D. 52 From the immunohistochemical results, DMP1 and FGF23 expressed in osteocytes were increased in both vibration groups at the fracture sites. Therefore, the promotion of DMP1 and FGF23 markers post-fracture presumably aids an initial and gradual progression of calcification, to maintain the microhardness 53 and mechanical strength of bone. At the late stage of healing, remodelling of the bony callus progressed. Both Sost and FGF23 were upregulated at day 42, and both showed significant enhancement in the OVX-VT group. Conversely, the falling intensity of DMP1 at day 42 in our study agreed that DMP1 declined during remodelling of the bony callus. 48 Hence, LMHFV augmented the regulatory role of osteocytes during the late phase of fracture healing by upregulating Sost and FGF23, as well as the downregulating DMP1 that signifies the suppression of osteoblastic action, progression of bone remodelling, and unified bone healing. 18 According to the spatial and temporal expression pattern after the treatment of vibration, it is postulated that osteocytes in the cortex could respond to the mechanical stimuli, thus enhancing the canalicular length and branch points that could potentially act as a mediator of the fractured surface, reconnecting the bone canaliculi of the lamellar bone in the cortex and woven trabecular within the injured matrix and the secreted bone matrix.
Development of bone requires an increment in mineral density and bone volume, 54, 55 however little about the role of osteocytes in mineralization in relations to healing of fractured bone has been described. Mineralization process is the laying down of immaturely calcified extracellular matrix followed by the gradual calcification with the deposit of minerals, increases in density, degradation of extracellular matrix, then eventually the increase in bone volume. 13 Our results from SEM-EDX showed that C/P and C/Ca ratios decreased during bone healing and were significantly lowered at day 42 in the SHAM-VT group. It suggested that the concentration of carbon, a characteristic of organic components, declined, while the concentrations of calcium and phosphorus, essential mineral components of bone, increased as calcification proceeded in bone healing and enhanced with vibration in osteoporotic bone. Furthermore, osteocyte markers DMP1 has also been suggested to exert direct effects on mineral formation, crystal growth, and indirect effects on regulation of calcium and phosphorous concentrations and matrix turnover in DMP1 KO mice. 56 The higher mineral content of the matrix at fracture site by LMHFV indicates the kinetics of the newly deposited bone, 57 progression of bone remodelling 20 and partially reflects an improved fracture toughness. 58 Besides, the results supported that bone volume fraction, trabecular thickness, and mechanical properties were enhanced at the earlier stage of osteoporotic metaphyseal fracture healing, and matured in quality with accelerated mineralization at later stages in the OVX-VT group. Taken together the enhancement effects of LMHFV on mineral content, the revitalization of LCN, the upregulated expression of DMP1 and its functions, findings of the present study further suggest the regulatory role of osteocyte in fracture healing is related to osteocytes' structural integrity and morphological presentations that would eventually lead to better mineralization and mechanical properties.
In this study, we further demonstrated the presence of impaired healing capacity in the osteoporotic bone. In comparison with the SHAM-CT group, the OVX-CT group exhibited more fibrous tissue and less osseous tissue in a metaphyseal model. In line with the histological results, the radiopacity was significantly lower for the OVX-CT group at day 42, which was also supported by a lower BV/TV in the OVX-CT groups amongst all groups at all time points. These findings showed less mature and decreased bone healing. Comparing the above results, the OVX-VT group exhibited a more positive response to LMHFV than the SHAM-VT group in terms of the osteocytes' morphology, expression of markers, bone parameters, mechanical properties, and mineralization status. The greater enhancement effect of LMHFV on the osteoporotic bone is likely to be related to the increment of estrogen receptor (ER), which acts as mechanical signal transduction molecules and exhibits delayed expression in ovariectomy-induced osteoporotic fracture. 59, 60 Of the various bone cells that are known to express ER-α, a subsiding ER-α expression was observed specifically in osteocytes after the menopause in older women. 61 With reference to our previous report, LMHFV can enhance ER-α expression in OVX-induced osteoporotic fracture healing, with improved mechanical signal transduction and callus formation. 59 Since osteocytes sense mechanical signals with the involvement of ERs and increase the expression of ER-α due to mechanical loading, 62 LMHFV might enhance the healing outcome in the osteoporotic fracture healing by expressing more ER-α 63 in osteocytes at the site of fracture, thereby mediating strain-related cascades for bone adaptation and osteogenic response. [64] [65] [66] Thus, the cumulative results suggested that the osteocytes in the osteoporotic bone respond more efficaciously to LMHFV, with a significant degree of enhancement in accelerating osteoporotic fracture healing.
This study utilized a new metaphyseal fracture rat model that primarily heals by intramembranous ossification instead of both endochondral ossification and intramembranous ossification that would be observed in a diaphyseal fracture model. The diaphyseal fracture model which has been extensively utilized in our previous studies involves intricate multistep processes, in which a combination of both intramembranous and endochondral ossification undergo to complete the healing. 67, 68 Conversely, metaphyseal fracture healing undergoes several distinct histological stages, including cellular activation and differentiation, woven bone formation, transformation of woven bone into lamellar bone and progression to further remodelling. 69 Diaphyseal fracture healing mostly involves indirect healing with the formation of periosteal callus, whereas direct healing only occurs under absolute stable condition. In contrast, direct healing is the usual mechanism in metaphyseal healing where endosteal bone bridging occurs with the absence of periosteal callus nor micro-callus. 70 The dominant process of intramembranous ossification in the metaphyseal healing suggested that osteocyte might be the dominant cell type that mediates the healing process, where progenitor cells directly differentiate into matrix-secreting osteoblasts along the periosteal and endosteal surfaces, and eventually achieve union with woven bone formation and remodelling of the calcified matrix. In addition, our metaphyseal fracture model adopted a fixation with plates and screws, which provides a relatively higher rigidity. Previous study reported that a rigid fixation could lead to a better healing outcome by shortening the time for endochondral ossification, 71 as compared to the traditional fixation of Kirschner wires in the diaphyseal fracture model. Plates and screws preserve osteocytes with a higher number present in the fracture site. 72 Therefore, this newly established fracture model has been adopted for this study because it has a stabilized fixation and healing mechanism that is very close to the clinical situation which would provide a new platform for further mechanistic study of osteocytes in fracture healing.
The limitation of this study was that quantification of osteocyte LCN was performed at the cortical bones adjacent to the fracture site due to very limited cells that could be identified at the newly formed trabecular bones at various healing phases. Moreover, the healing outcomes and observations in animal models do not fully simulate the human situation due to differences in metabolic rates and biomechanical reasons. In our study, an osteotomy-induced fracture model was adopted since a closed model can hardly perform a consistent metaphyseal fracture.
In principle, the ultimate strength of individual skeletal elements is determined by several factors, including microscopic morphology, organic and inorganic matrix composition and tissue structure. 73, 74 To the best of our knowledge, this is the first report to illustrate that LMHFV can positively reactivate the deteriorated morphology of osteocytes, mineral compositions, and structural properties in osteoporotic bone. The revitalized LCN was observed together with improved mineralization and accelerated healing in this newly established osteoporotic metaphyseal fracture animal model. The enhancement effect of LMHFV in terms of various indicators were greater in osteoporotic bone versus non-osteoporotic bone. Our data further support that OVX might not decrease the mechanical sensitivity of bone. Mechanical stimuli are of great importance to the elongation and outgrowth of osteocytic canaliculi for effective and efficient signal transmission.
In conclusion, the present study suggested that osteocyte is a crucial mechanosensor that plays a profound regulatory role in osteoporotic fracture healing. Our findings revealed that LMHFV enhanced osteocytes' structural integrity, protein expressions and accelerate the process of bone healing with better mineralization. Through a better understanding of the regulatory mechanism of osteocyte, more novel therapeutic strategies could be translated to improve the rate and quality of osteoporotic fracture healing.
